111 (YI) Net Income towards Common Stockholders Growth (3y) (2020 - 2025)
111 (YI) Net Income towards Common Stockholders Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 1.16% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 17.46% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 305.48% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | -10.77% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -46.22% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -46.65% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -5.09% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -83.72% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 81.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.09% |
| Sep 30, 2025 | 48.86% |
| Jun 30, 2025 | 42.32% |
| Mar 31, 2025 | 48.12% |
| Dec 31, 2024 | 46.22% |
| Sep 30, 2024 | 60.33% |
| Jun 30, 2024 | 57.22% |
| Mar 31, 2024 | 55.99% |
| Dec 31, 2023 | -13.96% |
| Sep 30, 2023 | 7.18% |
| Jun 30, 2023 | 15.59% |
| Mar 31, 2023 | 35.93% |
| Dec 31, 2022 | -39.81% |
| Sep 30, 2022 | -40.77% |
| Jun 30, 2022 | -43.81% |
| Mar 31, 2022 | -44.00% |
| Dec 31, 2021 | -43.49% |
| Sep 30, 2021 | -60.48% |
| Jun 30, 2021 | -22.00% |
| Mar 31, 2021 | -50.28% |